The scientists conclude that in mice «well - timed treatment with rIL - 27 improved lung injury and accelerated recovery without
affecting viral clearance» and continue «these data demonstrate that IL - 27 has a unique role in controlling immunopathology without impacting on host defense, and might therefore represent a promising candidate for
immunomodulatory therapy of viral pneumonia.»